BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16967247)

  • 1. Collateral branches IPMTs: secretin-enhanced MRCP.
    Carbognin G; Pinali L; Girardi V; Casarin A; Mansueto G; Mucelli RP
    Abdom Imaging; 2007; 32(3):374-80. PubMed ID: 16967247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia.
    Testoni PA; Mariani A; Curioni S; Giussani A; Masci E
    Am J Gastroenterol; 2009 Jul; 104(7):1780-6. PubMed ID: 19436288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging.
    Calculli L; Pezzilli R; Fiscaletti M; Casadei R; Brindisi C; Gavelli G
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):192-5. PubMed ID: 18397857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imaging of intraductal papillary mucinous tumor of the pancreas: literature review].
    Valette O; Cuilleron M; Debelle L; Antunes L; Mosnier JF; Régent D; Veyret C
    J Radiol; 2001 Jun; 82(6 Pt 1):633-45. PubMed ID: 11449165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does secretin stimulation add to magnetic resonance cholangiopancreatography in characterising pancreatic cystic lesions as side-branch intraductal papillary mucinous neoplasm?
    Purysko AS; Gandhi NS; Walsh RM; Obuchowski NA; Veniero JC
    Eur Radiol; 2014 Dec; 24(12):3134-41. PubMed ID: 25100335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
    Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
    J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretin-enhanced MR cholangiopancreatography: spectrum of findings.
    Tirkes T; Sandrasegaran K; Sanyal R; Sherman S; Schmidt CM; Cote GA; Akisik F
    Radiographics; 2013; 33(7):1889-906. PubMed ID: 24224585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secretin-enhanced magnetic resonance cholangiopancreaticography: value for the diagnosis of chronic pancreatitis].
    Heverhagen JT; Burbelko M; Schenck zu Schweinsberg T; Funke C; Wecker C; Walthers EM; Rominger M
    Rofo; 2007 Aug; 179(8):790-5. PubMed ID: 17594632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enhanced delineation of the pancreatic duct in MR cholangiopancreatography (MRCP) with a combined use of secretin].
    Takehara Y; Ichijo K; Tooyama N; Kodaira N; Fujiwara T; Yamamoto H; Watahiki H; Kaneko M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Mar; 55(4):255-6. PubMed ID: 7746728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal pancreatic exocrine function does not exclude MRI/MRCP chronic pancreatitis findings.
    Alkaade S; Cem Balci N; Momtahen AJ; Burton F
    J Clin Gastroenterol; 2008 Sep; 42(8):950-5. PubMed ID: 18645530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between secretin-enhanced MRCP findings and histopathologic severity of chronic pancreatitis in a cat model.
    Zhang TT; Wang L; Wang DB; Huang ZJ; Li YH; Lu JP
    Pancreatology; 2013; 13(5):491-7. PubMed ID: 24075513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
    Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
    Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia.
    Lankisch PG
    Am J Gastroenterol; 2010 Mar; 105(3):703-5. PubMed ID: 20203653
    [No Abstract]   [Full Text] [Related]  

  • 14. Concomitant intraductal papillary mucinous neoplasm and pancreatic endocrine tumour: Report of two cases and review of the literature.
    Larghi A; Stobinski M; Galasso D; Lecca PG; Costamagna G
    Dig Liver Dis; 2009 Oct; 41(10):759-61. PubMed ID: 19223252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreas divisum: evaluation with secretin-enhanced magnetic resonance cholangiopancreatography.
    Matos C; Metens T; Devière J; Delhaye M; Le Moine O; Cremer M
    Gastrointest Endosc; 2001 Jun; 53(7):728-33. PubMed ID: 11375579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation.
    Manfredi R; Costamagna G; Brizi MG; Maresca G; Vecchioli A; Colagrande C; Marano P
    Radiology; 2000 Mar; 214(3):849-55. PubMed ID: 10715057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance cholangiopancreatography reports in the evaluation of chronic pancreatitis: a need for quality improvement.
    Zuccaro P; Stevens T; Repas K; Diamond R; Lopez R; Wu B; Conwell DL
    Pancreatology; 2009; 9(6):764-9. PubMed ID: 20110743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR pancreatography: technique and applications.
    Takehara Y
    Top Magn Reson Imaging; 1996 Oct; 8(5):290-301. PubMed ID: 8914227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of early-stage chronic pancreatitis by secretin-enhanced magnetic resonance cholangiopancreatography.
    Czakó L
    J Gastroenterol; 2007 Jan; 42 Suppl 17():113-7. PubMed ID: 17238039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.